Previous analyses of cell line xenografts in mice and patient tumor tissue revealed that lapatinib treatment leads to a decreased distance between αSMA-positive stromal fibroblasts and proliferating HER2-positive breast cancer cells [5], implicating juxtacrine and/or distance-dependent paracrine signaling mechanisms such as those used by morphogens. Here, ACTA1 is linked to breast cancer.